HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Laryngeal Neoplasms D007822 7 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Pleural Effusion, Malignant D016066 6 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Respiratory Sounds D012135 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Hirschsprung Disease D006627 3 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Mercury Poisoning, Nervous System D020262 2 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Carcinosarcoma D002296 7 associated lipids
Eosinophilic Esophagitis D057765 3 associated lipids
Coccidioidomycosis D003047 2 associated lipids
Mucinoses D017520 2 associated lipids
Choroid Neoplasms D002830 2 associated lipids
Dysentery, Amebic D004404 3 associated lipids
Parotid Neoplasms D010307 2 associated lipids
Thyroid Nodule D016606 4 associated lipids
Glucagonoma D005935 2 associated lipids
Vascular Neoplasms D019043 2 associated lipids
Fetomaternal Transfusion D005331 1 associated lipids
Schistosomiasis haematobia D012553 1 associated lipids
Paraganglioma, Extra-Adrenal D010236 1 associated lipids
Mesonephroma D008649 1 associated lipids
Adenoma, Oxyphilic D018249 1 associated lipids
Adenoma, Pleomorphic D008949 1 associated lipids
Odontogenic Cyst, Calcifying D018333 1 associated lipids
Lip Neoplasms D008048 3 associated lipids
Prostatic Intraepithelial Neoplasia D019048 1 associated lipids
Granular Cell Tumor D016586 1 associated lipids
Tooth Attrition D019217 1 associated lipids
Acanthamoeba Keratitis D015823 1 associated lipids
Cystadenocarcinoma, Papillary D018283 1 associated lipids
Nevus, Epithelioid and Spindle Cell D018332 1 associated lipids
Neoplasms, Connective and Soft Tissue D018204 1 associated lipids
Congenital Hypothyroidism D003409 1 associated lipids
Rhabdomyoma D012207 1 associated lipids
Angiomyolipoma D018207 1 associated lipids
Sertoli Cell Tumor D012707 1 associated lipids
Neoplasms, Fibroepithelial D018225 1 associated lipids
Dientamoebiasis D004030 1 associated lipids
HIV Enteropathy D019053 1 associated lipids
Linear IgA Bullous Dermatosis D062027 1 associated lipids
Equine Infectious Anemia D004859 1 associated lipids
Sarcoma, Endometrial Stromal D018203 1 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Kim TJ et al. Increased expression of pAKT is associated with radiation resistance in cervical cancer. 2006 Br. J. Cancer pmid:16721365
Ichikawa W et al. Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer. 2004 Br. J. Cancer pmid:15354215
Beau-Faller M et al. Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping. 2009 Br. J. Cancer pmid:19293811
Berney DM et al. Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. 2009 Br. J. Cancer pmid:19293807
Rogers HA et al. An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET). 2009 Br. J. Cancer pmid:19293793
Kawanishi H et al. Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation. 2007 Br. J. Cancer pmid:17579624
Couvelard A et al. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. 2005 Br. J. Cancer pmid:15558070
Modok S et al. Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model. 2007 Br. J. Cancer pmid:17579620
Kupryjańczyk J et al. TP53 status determines clinical significance of ERBB2 expression in ovarian cancer. 2004 Br. J. Cancer pmid:15545967
Ishikawa K et al. Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer. 2008 Br. J. Cancer pmid:18506187
Bilim V et al. Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma. 2009 Br. J. Cancer pmid:19920820
Trinh XB et al. The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer. 2009 Br. J. Cancer pmid:19240722
Tang Z et al. Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer. 2008 Br. J. Cancer pmid:19238632
Buggy Y et al. Overexpression of the Ets-1 transcription factor in human breast cancer. 2004 Br. J. Cancer pmid:15365563
Baldewijns MM et al. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. 2007 Br. J. Cancer pmid:17505508
Aoyagi Y et al. Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. 2004 Br. J. Cancer pmid:15365564
Tajima Y et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions. 2004 Br. J. Cancer pmid:15354218
Pattje WJ et al. The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer. 2010 Br. J. Cancer pmid:20502457
Kim MS et al. Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias. 2008 Br. J. Cancer pmid:18392055
Moniaux N et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. 2008 Br. J. Cancer pmid:18392050
Elkahwaji JE et al. Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate. 2009 Br. J. Cancer pmid:19844236
Weinlich G et al. Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients. 2006 Br. J. Cancer pmid:16508630
Yamato I et al. Clinical importance of B7-H3 expression in human pancreatic cancer. 2009 Br. J. Cancer pmid:19844235
Shrout J et al. beta(2)microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients. 2008 Br. J. Cancer pmid:18506145
Andersen CL et al. Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. 2009 Br. J. Cancer pmid:19156145
de Micco C et al. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV. 2008 Br. J. Cancer pmid:18212751
Nehls O et al. Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX. 2007 Br. J. Cancer pmid:17426704
Sakamoto A et al. Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours. 2004 Br. J. Cancer pmid:15266333
McArdle PA et al. The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer. 2004 Br. J. Cancer pmid:15266325
Park SW et al. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. 2004 Br. J. Cancer pmid:15266310
Gaballah K et al. The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues. 2009 Br. J. Cancer pmid:19623179
Arnould L et al. Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism? 2006 Br. J. Cancer pmid:16404427
Went P et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. 2006 Br. J. Cancer pmid:16404366
Bingle L et al. Macrophages promote angiogenesis in human breast tumour spheroids in vivo. 2006 Br. J. Cancer pmid:16404363
Zou L et al. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. 2007 Br. J. Cancer pmid:17940506
Hettiaratchi A et al. The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer. 2007 Br. J. Cancer pmid:17311017
Heng B et al. Human papilloma virus is associated with breast cancer. 2009 Br. J. Cancer pmid:19724278
Woodhams JH et al. Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver. 2004 Br. J. Cancer pmid:15266317
Akahira JI et al. Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer. 2004 Br. J. Cancer pmid:15164121
Mc Cormack O et al. Growth arrest-specific gene 6 expression in human breast cancer. 2008 Br. J. Cancer pmid:18283315
Bilim V et al. Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis. 2008 Br. J. Cancer pmid:18283311
Clemons MJ et al. Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumours. 2002 Br. J. Cancer pmid:12087469
Pazgal I et al. Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma. 2002 Br. J. Cancer pmid:12087465
van't Land B et al. Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling. 2002 Br. J. Cancer pmid:12085266
Bhagavathula N et al. Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma. 2005 Br. J. Cancer pmid:16278666
Chou SC et al. Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas. 2004 Br. J. Cancer pmid:14760391
Garcia S et al. c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays. 2007 Br. J. Cancer pmid:17242702
Weigelt B et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. 2004 Br. J. Cancer pmid:15083181
Hagemann T et al. Molecular profiling of cervical cancer progression. 2007 Br. J. Cancer pmid:17242701
Olivier RI et al. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up. 2004 Br. J. Cancer pmid:15083174
Kommoss S et al. Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. 2007 Br. J. Cancer pmid:17242700
Stessels F et al. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. 2004 Br. J. Cancer pmid:15054467
Yao M et al. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. 2004 Br. J. Cancer pmid:14760389
Sriraksa R et al. CpG-island methylation study of liver fluke-related cholangiocarcinoma. 2011 Br. J. Cancer pmid:21448164
Preuss SF et al. Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer. 2008 Br. J. Cancer pmid:18212752
Wang JH et al. Detection of human parvovirus B19 in papillary thyroid carcinoma. 2008 Br. J. Cancer pmid:18212749
Mah-Becherel MC et al. Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model. 2002 Br. J. Cancer pmid:11875746
Duanmu J et al. Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy. 2011 Br. J. Cancer pmid:21427724
Weigelt B et al. No common denominator for breast cancer lymph node metastasis. 2005 Br. J. Cancer pmid:16189523
Koumakpayi IH et al. Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer. 2010 Br. J. Cancer pmid:20216540
Bluff JE et al. Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease. 2009 Br. J. Cancer pmid:19623180
Barros-Silva JD et al. Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. 2009 Br. J. Cancer pmid:19156142
Hamaguchi T et al. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. 2005 Br. J. Cancer pmid:15785749
Mizukami Y et al. Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. 2008 Br. J. Cancer pmid:18841157
Van der Auwera I et al. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. 2008 Br. J. Cancer pmid:18841156
Koga F et al. Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms. 2003 Br. J. Cancer pmid:12618884
Zheng HC et al. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. 2006 Br. J. Cancer pmid:17088917
Deans DA et al. Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer. 2006 Br. J. Cancer pmid:17088911
Franc B et al. Histological validation of diagnoses of thyroid cancer among adults in the registries of Belarus and the Ukraine. 2003 Br. J. Cancer pmid:14647144
Sheach LA et al. Androgen-related expression of G-proteins in ovarian cancer. 2009 Br. J. Cancer pmid:19623182
Rand V et al. Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma. 2008 Br. J. Cancer pmid:18781180
Debergh I et al. The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model. 2010 Br. J. Cancer pmid:20125158
Cellai C et al. Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086. 2006 Br. J. Cancer pmid:16721373
Liao YH et al. Upregulated ankyrin repeat-rich membrane spanning protein contributes to tumour progression in cutaneous melanoma. 2011 Br. J. Cancer pmid:21343931
Vlahovic G et al. Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation. 2006 Br. J. Cancer pmid:17003785
Kikuchi M et al. High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction. 2009 Br. J. Cancer pmid:19491899
Houston A et al. Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression. 2003 Br. J. Cancer pmid:14520470
Hori K and Saito S Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis. 2003 Br. J. Cancer pmid:14520469
Dufresne A et al. Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis. 2010 Br. J. Cancer pmid:20664593
Lau ST et al. Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-kappaB signalling pathways in human pancreatic adenocarcinoma cells. 2010 Br. J. Cancer pmid:20068565
Cellai I et al. In vivo effects of rosiglitazone in a human neuroblastoma xenograft. 2010 Br. J. Cancer pmid:20068562
Larsson A et al. Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer. 2011 Br. J. Cancer pmid:21829192
Nosho K et al. Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis. 2005 Br. J. Cancer pmid:15785755
Santin AD et al. Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy. 2005 Br. J. Cancer pmid:15785748
MacGrogan G et al. DNA topoisomerase IIalpha expression and the response toprimary chemotherapy in breast cancer. 2003 Br. J. Cancer pmid:12915875
Baker MJ et al. FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer. 2008 Br. J. Cancer pmid:18985044
Nakase Y et al. Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography. 2005 Br. J. Cancer pmid:15685235
Alazawi W et al. Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome. 2004 Br. J. Cancer pmid:15545968
Seenath MM et al. Reciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein bid in ex vivo colorectal cancer. 2008 Br. J. Cancer pmid:18648372
Landers KA et al. Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. 2008 Br. J. Cancer pmid:18648369
Modjtahedi H et al. Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10. 2012 Br. J. Cancer pmid:22315050
Yu J et al. Increased expression of survivin in gastric cancer patients and in first degree relatives. 2002 Br. J. Cancer pmid:12085263
Roka F et al. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis. 2005 Br. J. Cancer pmid:15700039
McCarty MF et al. ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer. 2004 Br. J. Cancer pmid:14760388
Wagenaar-Miller RA et al. Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction. 2003 Br. J. Cancer pmid:12778076
Manton KJ et al. Hypermethylation of the 5' CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis. 2005 Br. J. Cancer pmid:15685234
Tonetti DA et al. Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure. 2003 Br. J. Cancer pmid:12778068
Górka B et al. NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas. 2007 Br. J. Cancer pmid:17667921
Marotta A et al. Characterisation of integrin-linked kinase signalling in sporadic human colon cancer. 2003 Br. J. Cancer pmid:12771992
Minas V et al. Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation. 2007 Br. J. Cancer pmid:17667919